# Flu-Bu-Mel Conditioning Regimen for Myeloid Disease

> **NCT04269811** · PHASE2 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 49 (actual)

## Conditions studied

- Relapse Rate After Allo-HSCT

## Interventions

- **DRUG:** Flu-Bu-Mel

## Key facts

- **NCT ID:** NCT04269811
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-15
- **Primary completion:** 2023-03-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2023-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04269811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04269811, "Flu-Bu-Mel Conditioning Regimen for Myeloid Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04269811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*